Education
About Us
Working with TipRanks
Follow Us
Neogen (NEOG)
:NEOG
NEOG Stock Chart & Stats
Day’s Range― - ―
52-Week Range$8.31 - $18.58
Previous CloseN/A
Volume665.40K
Average Volume (3M)3.61M
Market Cap
$1.83B
Enterprise Value$3.83B
Total Cash (Recent Filing)$140.23M
Total Debt (Recent Filing)$892.44M
Price to Earnings (P/E)―
Beta1.30
Next Earnings
Apr 09, 2025EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.20
Shares Outstanding216,944,020
10 Day Avg. Volume6,342,413
30 Day Avg. Volume3,613,236
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.10
Price to Cash Flow (P/CF)11.90
P/FCF Ratio8.20
Enterprise Value/Market Cap2.09
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit8.25
Enterprise Value/Ebitda-11.21
Forecast
1Y Price Target
$13.00Price Target Upside54.21% Upside
Rating ConsensusHold
Number of Analyst Covering1
---
Neogen News
PremiumCompany Announcements
Neogen Earnings Call: Mixed Sentiments Amid Growth and Challenges
PremiumCompany Announcements
Neogen Corporation Reports Q2 2025 Earnings Highlights
---
Ownership Overview
0.25% Insiders
34.18% Mutual Funds
0.72% Other Institutional Investors
40.93% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NEOG FAQ
What was Neogen’s price range in the past 12 months?
Neogen lowest stock price was $8.31 and its highest was $18.58 in the past 12 months.
What is Neogen’s market cap?
Neogen’s market cap is $1.83B.
When is Neogen’s upcoming earnings report date?
Neogen’s upcoming earnings report date is Apr 09, 2025 which is in 12 days.
How were Neogen’s earnings last quarter?
Neogen released its earnings results on Jan 10, 2025. The company reported -$2.1 earnings per share for the quarter, missing the consensus estimate of -$0.012 by -$2.088.
Is Neogen overvalued?
According to Wall Street analysts Neogen’s price is currently Undervalued.
Does Neogen pay dividends?
Neogen does not currently pay dividends.
What is Neogen’s EPS estimate?
Neogen’s EPS estimate is -0.02.
How many shares outstanding does Neogen have?
Neogen has 216,944,020 shares outstanding.
What happened to Neogen’s price movement after its last earnings report?
Neogen reported an EPS of -$2.1 in its last earnings report, missing expectations of -$0.012. Following the earnings report the stock price went down -5.432%.
Which hedge fund is a major shareholder of Neogen?
Currently, no hedge funds are holding shares in NEOG
---
Neogen Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$13.00 (54.21% Upside)
$13.00 (54.21% Upside)
Blogger Sentiment
Bullish
NEOG Sentiment 70%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 430.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $418.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 3.0%
Last 30 Days ▼ 0.4%
Last 30 Days ▼ 0.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-43.80%
12-Months-Change
Fundamentals
Return on Equity
-16.38%
Trailing 12-Months
Asset Growth
-11.91%
Trailing 12-Months
Company Description
Neogen
Neogen Corporation (NEOG) is a company specializing in the development and marketing of products dedicated to food and animal safety. It operates in two main segments: Food Safety and Animal Safety. The company's core offerings include diagnostic test kits and related products for the detection of foodborne bacteria, natural toxins, food allergens, drug residues, and sanitation concerns. Neogen also provides a range of veterinary instruments, pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.
---
NEOG Company Deck
---
NEOG Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture with positive developments in core revenue growth, new product launches, and operational improvements. However, these were offset by significant challenges such as foreign exchange headwinds, declines in the genomics segment, production delays, and increased costs. Overall, the company is taking restructuring actions to address these issues, but the immediate financial outlook remains uncertain.Read More>---
NEOG Stock 12 Month Forecast
Average Price Target
$13.00
▲(54.21% Upside)
Technical Analysis
Best Analysts Covering NEOG
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-29.80%
initiated a buy rating 3 months ago
Copying Subbu Nambi's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -29.80% per trade.
---